- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03741218
Grape Polyphenols and Second-meal Effect (GRAPESECOND)
Potential Modulatory Effect of Whole Grape on Second-meal Tolerance in Obese Subjects: Role of Polyphenols
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Twenty-five subjects with obesity will be were recruited. Detailed inclusion and exclusion criteria are provided below.
The subjects will receive, after overnight fasting, either a monodose of freeze-dried grapes (equivalent to 300 g of fresh grapes) or isocaloric placebo solved in water, together with a high-fat breakfast. Blood samples will be collected before the intake, up to 5 h after breakfast, then a medium-fat lunch will be provided and blood samples will be collected for three additional hours. Both interventions will be separated by two weeks. The following determinations will be performed in blood samples collected at different periods: glucose, insulin, triglycerides, uric acid, viscosity, antioxidant capacity. Additionally, a satiety test will be provided. It is expected that grape supplementation, as compared with an isocaloric placebo, causes significant modifications in all the parameters indicated. Nevertheless, the primary outcome of this study is the area under the curve for glucose after the second meal (300-420 min from basal time).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Madrid, Spain, 28040
- Institute of Food Science, Technology and Nutrition, National Research Council (ICTAN-CSIC)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Obesity (BMI = 30-40 kg/m2).
Exclusion Criteria:
- Subjects with a pharmaceutical treatment set to modify blood pressure, lipid profile or glucose.
- Subjects with diagnoses of type 2 diabetes, cardiovascular diseases or thyroid diseases.
- Values above the following ones: glucose, > 115 mg/dL; triglycerides, > 350 mg/dL; total cholesterol, > 280 mg/dL; systolic blood pressure, > 150 mmHg; diastolic blood pressure, > 100 mmHg
- Previous bariatric surgery.
- Volunteers participating in other studies (currently or during last year) or weight loss plans.
- Pregnant or breastfeeding women.
- Adherence to vegetarian diets or usual consumption of dietary supplements.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
All subjects will receive a high-fat breakfast and a medium-fat lunch twice.
They will consume together with the breakfast the placebo (PLA) the first time and grape (GRAP) the second time.
|
The subjects will receive, after overnight fasting, either a monodose of freeze-dried grapes (equivalent to 300 g of fresh grapes) or isocaloric placebo solved in water, together with a high-fat breakfast.
Blood samples will be collected before the intake, up to 5 h after breakfast, then a medium-fat lunch will be provided and blood samples will be collected for three additional hours.
A total of 10 samples will be collected: 0-30-60-120-180-240-300-330-360-420 min.
Both interventions will be separated by two weeks.
Subjects will be instructed not to modify their dietary habits during the development of the study, but during the 72 h before each visit they will have to restrict the intake of polyphenol-rich foods (a detailed list will be provided).
|
Experimental: 2
All subjects will receive a high-fat breakfast and a medium-fat lunch twice.
They will consume together with the breakfast grape (GRAP) the first time and the placebo (PLA) the second time.
|
The subjects will receive, after overnight fasting, either a monodose of freeze-dried grapes (equivalent to 300 g of fresh grapes) or isocaloric placebo solved in water, together with a high-fat breakfast.
Blood samples will be collected before the intake, up to 5 h after breakfast, then a medium-fat lunch will be provided and blood samples will be collected for three additional hours.
A total of 10 samples will be collected: 0-30-60-120-180-240-300-330-360-420 min.
Both interventions will be separated by two weeks.
Subjects will be instructed not to modify their dietary habits during the development of the study, but during the 72 h before each visit they will have to restrict the intake of polyphenol-rich foods (a detailed list will be provided).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postprandial glucose (300-420 min)
Time Frame: Up to two months
|
Changes of postprandial blood glucose as result of supplementation with grapes, measured area under the curve for the period 300-420 min
|
Up to two months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postprandial glucose and insulin
Time Frame: Up to four months
|
Changes of blood glucose (0-320 min) and insulin (0-300 and 300-420 min) as result of supplementation with grapes
|
Up to four months
|
Plasma triglycerides
Time Frame: Up to four months
|
Changes of plasma triglycerides (0-300 and 300-420 min) as result of supplementation with grapes
|
Up to four months
|
Plasma uric acid
Time Frame: Up to four months
|
Changes of plasma uric acid (0-300 and 300-420 min) as result of supplementation with grapes
|
Up to four months
|
Plasma antioxidant capacity
Time Frame: Up to five months
|
Changes of plasma antioxidant capacity (0-300 and 300-420 min) as result of supplementation with grapes
|
Up to five months
|
Plasma viscosity
Time Frame: Up to six months
|
Changes of plasma viscosity (0-300 and 300-420 min) as result of supplementation with grapes.
|
Up to six months
|
Satiety
Time Frame: Up to three months
|
Changes of satiety (0-300 and 300-420 min) as result of supplementation with grapes.
|
Up to three months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Jara Pérez-Jiménez, PhD, Institute of Food Science, Technology and Nutrition (ICTAN-CSIC)
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HRG_2018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Istituto Auxologico ItalianoRecruiting
Clinical Trials on Freeze-dried grape (GRAP)/Placebo (PLA)
-
National University of SingaporeCalifornia Table Grape CommissionNot yet recruitingAging | Macula; Degeneration | Advanced Glycation End Products
-
University of ConnecticutCalifornia Table Grape CommissionCompletedMetabolic Syndrome XUnited States
-
University of California, DavisCompletedInflammation | Obesity | Cardiovascular Disease | Oxidative StressUnited States
-
National University of SingaporeNational University Hospital, Singapore; Ministry of Education, SingaporeActive, not recruitingAge-related Macular Degeneration | Eye HealthSingapore
-
University of MichiganCalifornia Table Grape CommissionNot yet recruitingPost-operative Atrial Fibrillation (POAF)United States
-
Case Western Reserve UniversityCalifornia Table Grape CommissionNot yet recruitingCrohn Disease
-
Texas Woman's UniversityThe California Table grape CommissionCompleted
-
Mayo ClinicNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Ohio UniversityCompletedInflammation | Sleep | Glucose RegulationUnited States
-
Florida State UniversityCalifornia Strawberry CommissionCompletedCardiovascular Diseases | Vascular Diseases | HypertensionUnited States